EU Fines H. Lundbeck A/S and Others $195 Million for Blocking Rival Drugs

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

European antitrust regulators fined nine drugmakers, including Denmark’s Lundbeck, a total of 146 million euros ($195 million) for blocking the supply of a cheaper anti-depressant to the market, the first EU sanction against such deals.

The punishments follow a 2009 report by the European Commission on the pharmaceutical sector, which said “pay-for-delay” agreements between companies lead to consumers paying as much as 20 percent more for their medicines.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC